CIS Pharmaceutical Forum
The only conference covering the entire CIS pharmaceutical sector including Kazakhstan, Uzbekistan, Moldova, Belarus, Armenia, Georgia, Azerbaijan, Kyrgyzstan, Tajikistan, Turkmenistan & more! More..
$74M to be invested in Azerbaijan’s first medicine plant
The Azerbaijani-Russian joint pharmaceutical plant will come to full production capacity in 2020, said Azerbaijan’s Economy Minister Shahin Mustafayev. He made the remarks Nov. 2 during the plant’s groundbreaking ceremony in the Pirallahi Industrial Park. This is Azerbaijan’s first pharmaceutical plant, said the minister, adding that a 10-percent share in the joint venture will be…
Kazakhstan and Hungary signed memorandum on expansion of pharmaceutical production
Within the framework of the Kazakh-Hungarian business forum the «Kaznex Invest» JSC, the JSC “International Research and Production Holding “Phytochemistry” and Hungarian company «PannonPharma LTD» signed a memorandum of understanding on organization and expansion of the production of original medicinal drugs based on plant matter in Karaganda. “Today we produce about 2 million ampules, about…
Global Pharmaceutical Regulatory Affairs Summit
Informa Life Sciences’ Global Pharmaceutical Regulatory Affairs Summit, taking place on 27th – 29th October 2015 in Berlin, Germany, combines two previously separate events, ‘Regulatory Affairs in Emerging Markets’ and ‘Global eSubmissions’ to bring you increased networking and 3 highly focussed streams. Stream 1: Regulatory Affairs in Russia, CIS, Turkey and MENA Stream 2: Regulatory…
Central European private spending on health to exceed €21bn
Private healthcare markets in Central Europe are still young markets replete with opportunities. There is substantial demand for such services in the countries analysed in the most recent PMR report “Private healthcare market in Central Europe 2016. Development forecasts for 2016-2021” because of the rise of the middle and upper classes and the increase in…
EMA Releases List of Medical Events for Pharmacovigilance Monitoring
The European Medicines Agency (EMA) has released a list of standardized terms describing medical events it says will be used by the agency and other European regulators to identify suspected adverse events. EMA says the list will assist it and other regulators to prioritize the review of suspected adverse events that “deserve special attention, irrespective…
Hungary spends 745 M EUR on hospital developments in Budapest
The government has allocated around 235 billion forints (EUR 754.6m) towards the first phase of hospital development and upgrades planned in the capital which are scheduled to begin at the beginning of next year at the latest, the government commissioner for hospital developments told daily Magyar Idők on Saturday. Most of the funds, around 185…
Medicinessafety monitoring : StatusandProspects
Based on the WHO definition pharmacovigilance is “scientific research related to the detection, assessment, understanding and prevention of adverse reactions or any other problems associated with medical drugs.” The ” thalidomide tragedy” caused creation of pharmacovigilance in EU. During just a few years of existing on the drug market, thalidomide became the cause of birth…
Changes in pricing of medical products
Belarus: Decree no 228 of 21 June 2016 establishes new rules for pricing of pharmaceuticals, medical devices and medical equipment (“medical products”). The new rules entered into force on 1 July 2016. We are glad to introduce you the most important changes. 1. Sale prices of medical products produced in Belarus and estimated sale prices of…
Sales of mid- and high-priced drugs in Russia continue to decline
Sales of mid- and high-priced drugs in Russia are steadily declining, due to the ongoing economic stagnation in the country and the consequences of the financial crisis, reports The Pharma Letter’s local correspondent. According to a recent report, published by the Russian Ministry of Health, such negative trends force Russian patients to shift to cheaper…